Related Experiment Video
Updated: Jun 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Impact of renal dysfunction on long-term survival after isolated coronary artery bypass surgery
1Department of Cardiovascular Surgery and Research Center for Cardiovascular Regenerative Medicine, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Insights
The Cockcroft-Gault formula best predicts in-hospital mortality after coronary artery bypass grafting (CABG), outperforming the MDRD equation and serum creatinine. This estimated glomerular filtration rate (eGFR) method improves risk assessment for patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Medical Statistics
Background:
- Preoperative renal dysfunction is a key predictor of adverse cardiovascular events post-coronary artery bypass grafting (CABG).
- Serum creatinine was historically used, but estimated glomerular filtration rate (eGFR) is now recommended.
- The predictive accuracy of the Cockcroft-Gault formula versus the MDRD equation for long-term outcomes after CABG remains unclear.
Purpose of the Study:
- To compare the predictive effectiveness of the Cockcroft-Gault formula, MDRD equation, and serum creatinine.
- To evaluate these markers for both in-hospital and long-term mortality following CABG.
Main Methods:
- Retrospective review of 5559 patients undergoing isolated CABG (1999-2005).
- Utilized receiver operating characteristic (ROC) curves and Cox regression analysis.
- Compared prediction accuracy for in-hospital and long-term mortality.
Main Results:
- The Cockcroft-Gault formula demonstrated superior accuracy for predicting in-hospital mortality (AUC=0.755, p<0.001).
- eGFR by Cockcroft-Gault independently predicted in-hospital (OR=4.51) and long-term mortality (HR=1.54).
- Both eGFR formulas outperformed serum creatinine in risk assessment.
Conclusions:
- Both eGFR formulas offer better risk assessment than serum creatinine for CABG patients.
- The Cockcroft-Gault formula is superior to the MDRD equation for predicting in-hospital mortality post-CABG.
Background:
Preoperative renal dysfunction has been an important predictor for adverse cardiovascular events after coronary artery bypass grafting (CABG). In the past, serum creatinine was widely used to assess renal function. Until recently, estimated glomerular filtration rate (eGFR) was recommended in evaluating renal function. The Cockcroft-Gault formula and the Modification of Diet in Renal Disease (MDRD) equation are two widely used formulas in clinical practice. Which method best predicts long-term outcome after CABG is still unknown. This study compared the predictive effectiveness of the Cockcroft-Gault formula, the MDRD equation, and serum creatinine level for in-hospital and long-term mortality.
Methods:
We retrospectively reviewed data collected from 5559 patients who underwent isolated CABG at Fuwai Hospital from January 1999 to December 2005. The main outcomes were in-hospital and long-term mortality. Receiver operating characteristic (ROC) curves and Cox analysis were used for the comparison.
Results:
Mean follow-up was 56.5 +/- 24.6 months. ROC curve analysis showed that the Cockcroft-Gault formula had the greatest accuracy for predicting in-hospital mortality (area under the curve, 0.755; p < 0.001). Multivariate analysis confirmed that the eGFR based on the Cockcroft-Gault formula was an independent predictor of in-hospital (odds ratio, 4.51, p < 0.001) and long-term (hazard ratio, 1.54; p = 0.003) mortality. Both formulas were better than the serum creatinine level.
Conclusions:
Both formulas could provide a better measure of risk assessment than serum creatinine for in-hospital and long-term mortality. The Cockcroft-Gault formula was better than the MDRD equation for predicting in-hospital mortality.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury III: Clinical Manifestations
Heart Failure Drugs: Diuretics
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
